A Stem Cell–Based Approach to Cartilage Repair
暂无分享,去创建一个
Peter G. Schultz | Matthew S. Tremblay | Kristen Johnson | P. Schultz | C. Cho | L. Bouchez | Kristen A. Johnson | Xu Wu | Shoutian Zhu | Joshua N. Payette | Jianing Wang | Laure C. Bouchez | Shelly Meeusen | Alana Althage | Charles Y. Cho | A. Althage | Shoutian Zhu | Shelly L Meeusen | Xu Wu | Jianing Wang
[1] P. Schultz,et al. A small molecule accelerates neuronal differentiation in the adult rat , 2010, Proceedings of the National Academy of Sciences.
[2] Ericka Stricklin-Parker,et al. Ann , 2005 .
[3] David J. Hunter,et al. Pharmacologic therapy for osteoarthritis—the era of disease modification , 2011, Nature Reviews Rheumatology.
[4] J. Reginster,et al. Introduction and WHO perspective on the global burden of musculoskeletal conditions. , 2002, Rheumatology.
[5] Y. Wang,et al. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells , 2007, Oncogene.
[6] Kozo Nakamura,et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. , 2006, Arthritis and rheumatism.
[7] S. Koelling,et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. , 2009, Cell stem cell.
[8] S. Shapiro,et al. Filamin A-Bound PEBP2β/CBFβ Is Retained in the Cytoplasm and Prevented from Functioning as a Partner of the Runx1 Transcription Factor , 2005, Molecular and Cellular Biology.
[9] P. Schultz,et al. A small molecule primes embryonic stem cells for differentiation. , 2009, Cell stem cell.
[10] J H Hartwig,et al. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring , 1990, The Journal of cell biology.
[11] D. Levanon,et al. Structure and regulated expression of mammalian RUNX genes , 2004, Oncogene.
[12] W. B. van den Berg,et al. Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. , 1989, The American journal of pathology.
[13] A. Dray,et al. Osteoarthritic pain: a review of current, theoretical and emerging therapeutics , 2008, Expert opinion on investigational drugs.
[14] Makoto Sato,et al. Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.
[15] Gerald N. Smith. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis. , 2006, Frontiers in bioscience : a journal and virtual library.
[16] E. Cameron,et al. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival , 2008, Oncogene.
[17] D. Saris,et al. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection , 2010, Arthritis research & therapy.
[18] J. E. Thompson,et al. A Commentary on the Dresden Codex, a Maya Hieroglyphic Book , 1973 .
[19] D. D’Lima,et al. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis , 2009, Arthritis research & therapy.
[20] G. Stein,et al. Identification of novel protein/DNA interactions within the promoter of the bone‐related transcription factor Runx2/Cbfa1 , 2002, Journal of cellular biochemistry.
[21] S. K. Zaidi,et al. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression , 2004, Oncogene.
[22] P. D. Kraan,et al. A role for age-related changes in TGFβ signaling in aberrant chondrocyte differentiation and osteoarthritis , 2010 .
[23] S. Mundlos,et al. Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.
[24] S. Glasson,et al. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. , 2007, Osteoarthritis and cartilage.
[25] S. Jimenez,et al. Osteoarthritis cartilage histopathology: grading and staging. , 2006, Osteoarthritis and cartilage.
[26] A. Uitterlinden,et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. , 2004, Arthritis and rheumatism.
[27] Andrés J. García,et al. Interactions between integrin ligand density and cytoskeletal integrity regulate BMSC chondrogenesis , 2008, Journal of cellular physiology.
[28] L. Castilla,et al. Function of CBFβ/Bro proteins , 2000 .
[29] M. Lotz. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options , 2010 .
[30] D. Heinegård,et al. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. , 1994, Annals of the rheumatic diseases.
[31] S. Goldring,et al. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis , 2010, Annals of the New York Academy of Sciences.
[32] E. Schwarz,et al. Runx3/AML2/Cbfa3 Regulates Early and Late Chondrocyte Differentiation , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] T. Komori. Signaling networks in RUNX2‐dependent bone development , 2011, Journal of cellular biochemistry.
[34] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[35] E. Schwarz,et al. Runx1/AML1/Cbfa2 Mediates Onset of Mesenchymal Cell Differentiation Toward Chondrogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] C. De Bari,et al. The regulation of differentiation in mesenchymal stem cells. , 2010, Human gene therapy.
[37] H. Fahmi,et al. Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis , 2010, Arthritis Research & Therapy.
[38] Y. Maugars,et al. From osteoarthritis treatments to future regenerative therapies for cartilage. , 2009, Drug discovery today.